Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Sanctions Eli Lilly's Easier-To-Use GLP-1 Weight Loss Pill Foundayo
CNN: Another GLP-1 Weight Loss Pill Gets FDA Approval, And It Has Fewer Restrictions On How It’s Used
The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a rapidly growing arsenal of obesity therapies. (Tirrell, 4/1)
Fox News: Ozempic And Mounjaro Use Blamed For Leaving Potato Farmers With Unusual Surplus
The rapid rise of weight-loss injections is reshaping the quantity of food people eat — leaving farmers in some areas with a growing surplus of unsold potatoes. (McGreal, 4/1)
MedPage Today: Large GLP-1 Drug Review Takes Closer Look At Risks, Rewards
GLP-1 medications showed a range of potential benefits and safety concerns in an umbrella review of non-cardiometabolic outcomes, though the data quality for many remained limited. (Monaco, 3/31)
In other tech news —
Becker's Hospital Review: Meta Gets Into Health Wearables With AI Glasses
Meta is entering the health wearables market with AI glasses designed to keep tabs on what you eat. The Meta AI glasses are now available for people with prescription lenses and come with hands-free food tracking as part of a software update. Via a voice prompt or photo, wearers can log what they eat, with the glasses extracting nutrition details and logging them into the Meta AI app. (Bruce, 4/1)
The Baltimore Sun: Howard Teens Develop Device To Help Those With Dementia
Millions of people with dementia work hard to complete everyday tasks, from taking medication to locking the door. For families, keeping track of these small but essential routines can be exhausting, and missing a step can have serious consequences. Seeing a need through community and family, four juniors from Mount Hebron High School — Saanvi Kakarlapudi, 16; Ahana Roy, 16; Amitha Sabbani, 16; and Tanvi Anand, 17 — developed MindLink, a wearable device designed to act as an automatic to-do list. (Yelenik, 4/1)
AP: Virtual Replicas Of Patients' Hearts Help Doctors Tackle Irregular Heartbeat
Scientists created virtual replicas of patients’ diseased hearts so precise that blocking a dangerous irregular heartbeat in these digital “twins” showed doctors how to better treat the real thing. One of the first clinical trials of these custom models suggests it might improve care for ventricular tachycardia, a notoriously difficult-to-treat arrhythmia that is a major cause of sudden cardiac arrest, blamed for about 300,000 U.S. deaths a year. (Neergaard, 4/1)
